Contemporary Analysis in Pancreatic Enzyme Use in the Nova Scotian Cystic Fibrosis Population

Written by Sanja Stanojevic
View this poster

Presented at the Dalhousie/Nova Scotia Health Department of Medicine Research Day 2025.

Sanja Stanojevic
Previous

An Environmental Scan of Canadian Newborn Screening Programs for Cystic Fibrosis
Next

The impact of applying 2019 ATS/ERS quality control standards for spirometry to a large cohort study compared with the 2005 standard